Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, ProQR Therapeutics N.V (NASDAQ: PRQR) closed at $3.45 up 4.23% from its previous closing price of $3.31. In other words, the price has increased by $4.23 from its previous closing price. On the day, 1.38 million shares were traded. PRQR stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.45.
Ratios:
For a deeper understanding of ProQR Therapeutics N.V’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.73 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on Oct-30-24, Upgraded its rating to Strong Buy and sets its target price to $14 from $6 previously.
On November 08, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.
JMP Securities Upgraded its Mkt Perform to Mkt Outperform on March 30, 2023, whereas the target price for the stock was revised from $1.50 to $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRQR now has a Market Capitalization of 281796704 and an Enterprise Value of 204833680. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.93 while its Price-to-Book (P/B) ratio in mrq is 8.00. Its current Enterprise Value per Revenue stands at 12.985 whereas that against EBITDA is -7.496.
Stock Price History:
Over the past 52 weeks, PRQR has reached a high of $4.62, while it has fallen to a 52-week low of $1.13. The 50-Day Moving Average of the stock is 52.47%, while the 200-Day Moving Average is calculated to be 67.16%.
Shares Statistics:
For the past three months, PRQR has traded an average of 1.21M shares per day and 7230080 over the past ten days. A total of 78.46M shares are outstanding, with a floating share count of 52.75M. Insiders hold about 35.41% of the company’s shares, while institutions hold 22.17% stake in the company. Shares short for PRQR as of 1728950400 were 133298 with a Short Ratio of 0.11, compared to 1726185600 on 158686. Therefore, it implies a Short% of Shares Outstanding of 133298 and a Short% of Float of 0.22999999999999998.
